aTyr Pharma | LIFE - Eigenkapital Und Reserven





Eigenkapital Und Reserven Veränderung Datum
Alterity Therapeutics Limited AUD 36.21M 18.58M 2025-12
Ardelyx USD 148.62M 18.33M 2026-03
aTyr Pharma USD 48.79M 9.15M 2026-06
Biogen USD 18.85B 196.3M 2026-06
Bristol-Myers Squibb USD 22.32B 2.25B 2026-06
Cipla INR 344.32B 15.13B 2026-03
Clal Biotechnology ILS 121.41M 4.62M 2023-12
Compugen USD 95.35M 7.38M 2026-03
CSL USD 18.66B 2.75B 2025-12
Curis USD 12.71M 7.24M 2026-03
GlaxoSmithKline GBP 17.64B 223M 2026-06
Grifols EUR 6.21B 133.12M 2025-12
Lakefront Biotherapeutics EUR 3.26B 10.26M 2026-06
Novartis USD 41.95B 3.02B 2026-06
Roche Holding CHF 32.69B 1.11B 2026-06
United Therapeutics USD 6.4B 499.2M 2026-06